Eisenmenger Syndrome Clinical Trial
Official title:
Eisenmenger Syndrome in the Nordic Countries: Advanced Treatment and Mortality 1977-2012
This is a historical cohort study with retrospective collection of data comprising all Nordic patient's diagnosed with Eisenmengers syndrome in the period 1977 through 2011. The goal is to determine prognostic factors for mortality and morbidity.
The following variables are obtained from national registries for each individual fulfilling
the inclusion criteria:
- Personal data: Gender, day of birth, vital status (dead/alive), date of death, cause of
death, all cause hospitalization days
- Specific cardiac malformation diagnosis
- Heart-lung transplantation.
- Social data: Highest educational level, marital status, employment status (Denmark
only)
Primary endpoints
- Incidence and prevalence of Eisenmenger Syndrome
- All-cause mortality
- All-cause morbidity (hospitalization for any cause)
- Heart-lung transplantation
- Advanced treatment
- Mortality with AT
- Highest educational level
- Personal income
- Marital status
- Job status
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00303004 -
Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
|
Phase 3 | |
Recruiting |
NCT05611268 -
Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
|
N/A | |
Completed |
NCT02614417 -
Sleep-disordered Breathing in Eisenmenger Syndrome
|
N/A | |
Recruiting |
NCT01397110 -
Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects
|
N/A | |
Completed |
NCT01200732 -
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
|
Phase 2 | |
Completed |
NCT02119442 -
Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves
|
N/A | |
Recruiting |
NCT01683981 -
Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
|
Phase 0 | |
Completed |
NCT00266162 -
Bosentan in Treatment of Pulmonary Arterial Hypertension
|
Phase 4 |